Loading clinical trials...
Loading clinical trials...
A Single and Repeat Dosing Study of the Safety, Drug Exposure and Clinical Activity of R-2487 in Patients With Rheumatoid Arthritis
Conditions
Interventions
R-2487 DP
Locations
5
United States
University of California, San Diego
San Diego, California, United States
St.Jude Clinical Research
Doral, Florida, United States
AP Medical Research
Miami, Florida, United States
Altoona Center for Research
Duncansville, Pennsylvania, United States
Prolato Clinical Research Center
Houston, Texas, United States
Start Date
October 19, 2023
Primary Completion Date
November 30, 2026
Completion Date
December 31, 2026
Last Updated
September 23, 2025
NCT07017686
NCT05038553
NCT05790356
NCT05657847
NCT03429426
NCT06028438
Lead Sponsor
Rise Therapeutics LLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions